Evidence map›Paper›PMID 31118252›Full record

ArticleJournal of virology2019

GII.13/21 Noroviruses Recognize Glycans with a Terminal β-Galactose via an Unconventional Glycan Binding Site.

Xin Cong, Xiao-Man Sun, Jian-Xun Qi, Han-Bo Li, Wen-Gang Chai, Qing Zhang, Hong Wang, Xiang-Yu Kong, Jiao Song, Li-Li Pang and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Xin Cong *Key Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Xiao-Man Sun *Key Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Jian-Xun Qi *Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Han-Bo LiKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Wen-Gang ChaiGlycosciences Laboratory, Department of Medicine, Imperial College London, London, United Kingdom.
Qing ZhangKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Hong WangKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Xiang-Yu KongKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Jiao SongSchool of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Li-Li PangKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Miao JinKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Dan-di LiKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China.
Ming TanDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Zhao-Jun DuanKey Laboratory for Medical Virology and Viral Diseases, National Health Commission of the People's Republic of China, Beijing, China zhaojund@126.com.
National Health and Family Planning Commission · CNChinese Center For Disease Control and Prevention · CNNational Institute for Viral Disease Control and Prevention · CNCincinnati Children's Hospital Medical Center · USGansu University of Traditional Chinese Medicine · CNImperial College London · GBInstitute of Microbiology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human noroviruses (huNoVs) recognize histo-blood group antigens (HBGAs) as host susceptibility factors. GII.13 and GII.21 huNoVs form a unique genetic lineage that emerged from mainstream GII NoVs via development of a new, nonconventional glycan binding site (GBS) that binds Le

Indexed as

Virus AttachmentBlood Group AntigensCA-19-9 AntigenGalactoseGenotypeHumansNorovirusProtein BindingBlood Group AntigensCA-19-9 AntigenGalactosecrystal structureglycanhisto-blood group antigenshuman norovirusviral receptor

Identifiers

PMID31118252
PMCPMC6639292
OpenAlexW2945562023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.